Great West Life Assurance CO Biomarin Pharmaceutical Inc Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

A detailed history of Great West Life Assurance CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 213,344 shares of BMRN stock, worth $14 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
213,344
Previous 199,757 6.8%
Holding current value
$14 Million
Previous $16.5 Million 8.82%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$69.02 - $93.84 $937,774 - $1.28 Million
13,587 Added 6.8%
213,344 $15 Million
Q2 2024

Aug 12, 2024
BUY
$74.43 - $92.22 $7.89 Million - $9.77 Million
105,963 Added 112.97%
199,757 $16.5 Million
Q1 2024

May 13, 2024
SELL
$83.81 - $99.0 $257,464 - $304,128
-3,072 Reduced 3.17%
93,794 $8.2 Million
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $596,878 - $771,431
-7,831 Reduced 7.48%
96,866 $9.28 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $385,707 - $428,372
-4,534 Reduced 4.15%
104,697 $9.26 Million
Q2 2023

Aug 10, 2023
SELL
$86.68 - $100.3 $90,840 - $105,114
-1,048 Reduced 0.95%
109,231 $9.53 Million
Q1 2023

May 12, 2023
SELL
$87.74 - $117.27 $191,185 - $255,531
-2,179 Reduced 1.94%
110,279 $10.7 Million
Q4 2022

Feb 10, 2023
BUY
$80.93 - $108.63 $457,740 - $614,411
5,656 Added 5.3%
112,458 $11.7 Million
Q3 2022

Nov 01, 2022
BUY
$82.16 - $96.94 $8.77 Million - $10.4 Million
106,802 New
106,802 $9.04 Million
Q2 2022

Aug 09, 2022
SELL
$71.48 - $86.85 $912,299 - $1.11 Million
-12,763 Reduced 8.36%
139,947 $11.6 Million
Q1 2022

May 12, 2022
SELL
$74.28 - $92.69 $334,854 - $417,846
-4,508 Reduced 2.87%
152,710 $12.5 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $1.49 Million - $1.9 Million
20,734 Added 15.19%
157,218 $13.9 Million
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $78,358 - $89,572
1,048 Added 0.77%
136,484 $10.6 Million
Q2 2021

Aug 11, 2021
SELL
$75.51 - $84.79 $373,547 - $419,456
-4,947 Reduced 3.52%
135,436 $11.3 Million
Q1 2021

May 17, 2021
BUY
$74.73 - $90.69 $896,535 - $1.09 Million
11,997 Added 9.34%
140,383 $10.5 Million
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $281,654 - $349,885
3,879 Added 3.12%
128,386 $11.2 Million
Q3 2020

Nov 13, 2020
BUY
$71.87 - $131.03 $60,658 - $110,589
844 Added 0.68%
124,507 $9.47 Million
Q2 2020

Aug 17, 2020
BUY
$79.55 - $124.22 $477,300 - $745,320
6,000 Added 5.1%
123,663 $15.2 Million
Q1 2020

May 14, 2020
BUY
$71.37 - $96.85 $215,751 - $292,777
3,023 Added 2.64%
117,663 $10 Million
Q4 2019

Feb 11, 2020
BUY
$64.27 - $86.37 $45,888 - $61,668
714 Added 0.63%
114,640 $9.69 Million
Q3 2019

Oct 25, 2019
BUY
$67.4 - $85.11 $438,167 - $553,300
6,501 Added 6.05%
113,926 $7.68 Million
Q2 2019

Jul 31, 2019
SELL
$80.35 - $93.9 $70,547 - $82,444
-878 Reduced 0.81%
107,425 $0
Q1 2019

May 08, 2019
BUY
$84.2 - $98.62 $1.98 Million - $2.32 Million
23,489 Added 27.69%
108,303 $9.58 Million
Q3 2018

Nov 13, 2018
SELL
$93.92 - $105.72 $1.19 Million - $1.34 Million
-12,678 Reduced 13.0%
84,814 $8.23 Million
Q2 2018

Aug 10, 2018
BUY
$76.01 - $99.03 $41,349 - $53,872
544 Added 0.56%
97,492 $9.19 Million
Q1 2018

May 10, 2018
SELL
$77.67 - $92.63 $185,320 - $221,015
-2,386 Reduced 2.4%
96,948 $7.87 Million
Q4 2017

Feb 09, 2018
BUY
$80.76 - $95.13 $316,417 - $372,719
3,918 Added 4.11%
99,334 $8.84 Million
Q3 2017

Nov 09, 2017
BUY
$80.6 - $94.95 $7.69 Million - $9.06 Million
95,416
95,416 $8.86 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email